Forest Laboratories Management Discusses Q3 2013 Results – Earnings Call

Forest Laboratories Management Discusses Q3 2013 Results – Earnings Call

Filed under: drug treatment centers

For R&D, in November, we and our partner Gedeon Richter announced that we submitted a New Drug Application to the FDA for cariprazine for the treatment of schizophrenia and bipolar mania. This NDA submission marks 9 for 9 …. Our promotional effort …
Read more on Seeking Alpha

 

Covidien Begins SWIFT PRIME Study

Filed under: drug treatment centers

The device has won the approval of the U.S. Food and Drug Administration (“FDA”) in March 2012 and is already approved outside the U.S. for the endovascular treatment of acute ischemic stroke, offering physicians with an innovative treatment technology …
Read more on Zacks.com

 

Passages Addiction Treatment Centers Complete Annual JCAHO Staff Training

Filed under: drug treatment centers

Passages, the world renowned addiction treatment facility with centers in Malibu and Ventura California, recently completed the annual JCAHO compliance training necessary for the continuation of this highly coveted healthcare accreditation. The Joint …
Read more on Melodika.net (press release)